文献速递肺外科

剑突下胸腔镜解剖性肺切除术后第1天出院:单中心ERAS经验

Postoperative day 1 discharge following subxiphoid thoracoscopic anatomical lung resection: a single-centre, postoperative enhanced recovery experience.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

本研究回顾性分析201例剑突下多孔胸腔镜解剖性肺切除患者,其中56%于术后第1天出院。多因素分析显示年龄>74岁和手术时长与POD1后出院相关,FEV1和复杂亚肺叶切除与POD1出院相关。POD1出院患者ERAS依从性更好,出院后体验更佳且疼痛评分相似,结论认为在适当选择患者中POD1出院可安全实现。

要点

  • 201例中56%于POD1出院,肺叶切除49%、简单亚肺叶切除59%、复杂亚肺叶切除68%。
  • POD0拔除胸管58例(29%),POD1无胸管138例(69%)。
  • POD1出院患者ERAS依从性更好,出院后体验更佳且疼痛评分相似。

核心结论

  • 在适当选择的患者中,剑突下胸腔镜解剖性肺切除术后第1天出院可安全实现,结局优良且恢复质量高,早期拔除胸管是关键的ERAS路径要素。

研究设计与样本

  • 单中心回顾性分析前瞻性收集的数据,纳入2020年1月至2022年1月连续201例接受剑突下多孔胸腔镜解剖性肺切除的患者,包括108例肺叶切除和93例亚肺叶切除(59例复杂和34例简单)。

主要发现

  • 113例(56%)于POD1出院,其中肺叶切除后49%、简单亚肺叶切除后59%、复杂亚肺叶切除后68%。
  • 多因素分析中,年龄>74岁和手术时长与POD1后出院相关,FEV1和复杂亚肺叶切除与POD1出院相关。
  • POD0拔除胸管58例(29%),POD1无胸管138例(69%)。
  • 院内并发症发生率13%,90天再入院率10%(POD1出院者7% vs POD1后出院者14%),90天死亡率0.5%。
  • POD1出院患者ERAS路径依从性更好,表现为早期拔除胸管和无阿片类镇痛;出院后恢复质量调查显示POD1出院者回家体验更好,疼痛评分相似。

关键数值与推荐

  • POD1出院比例56%(113/201),肺叶切除后49%、简单亚肺叶切除后59%、复杂亚肺叶切除后68%。
  • POD0拔除胸管29%(58例),POD1无胸管69%(138例)。
  • 院内并发症13%,90天再入院10%(POD1出院7% vs POD1后出院14%),90天死亡0.5%。

临床怎么用

  • 在高级ERAS项目中,剑突下胸腔镜解剖性肺切除术后POD1出院可作为适当选择患者的安全策略,早期拔除胸管是支持该路径的关键要素。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The goal of this study was to assess the safety and quality of recovery (QOR) after discharge on postoperative day (POD) 1 following subxiphoid thoracoscopic anatomical lung resection within an advanced Enhanced Recovery After Surgery (ERAS) program. METHODS: A retrospective analysis of prospectively collected data was conducted. Characteristics, perioperative and outcome data, compliance with ERAS pathways and a home-transition QOR survey were analysed using a multivariable logistic regression model. RESULTS: From January 2020 to January 2022, a total of 201 consecutive patients underwent subxiphoid multiportal thoracoscopic anatomical lung resection, comprising 108 lobectomies and 93 sublobar resections (SLRs) (59 complex SLRs and 34 simple SLRs). Among them, 113 patients (56%) were discharged on POD 1, 49% after a lobectomy, 59% after a simple sublobar resection and 68% after a complex sublobar resection. In the multivariable analysis, age > 74 years and duration of the operation were associated with discharge after POD 1, whereas forced expiratory volume in 1 s and complex SLRs were associated with discharge on POD 1. Chest tube removal was achieved on POD 0 in 58 patients (29%), and 138 patients (69%) were free from a chest tube on POD 1. There were 13% with in-hospital morbidity, 10% with 90-day readmission (7% after POD 1 discharge and 14% in patients discharged after POD 1), and 0.5% with 90-day mortality. Patients discharged on POD 1 showed better compliance with the ERAS pathway with early chest tube removal and opioid-free analgesia. The home-transition QOR survey reported a better experience of returning home after discharge on POD 1 and similar pain scores. CONCLUSIONS: Postoperative day 1 discharge can be safely achieved in appropriately selected patients after subxiphoid thoracoscopic anatomical lung resection, with excellent outcomes and high quality of recovery, supported by early chest tube removal as a determinant ERAS pathway.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Pfeuty K, Rojas D, Iquille J, et al. Postoperative day 1 discharge following subxiphoid thoracoscopic anatomical lung resection: a single-centre, postoperative enhanced recovery experience. Eur J Cardiothorac Surg. 2024. PMID: 38857446. doi:10.1093/ejcts/ezae230

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。